• Username (E-mail)
  • Password
Dow 20,822 0.1%  EStoxx50 3,304 -0.9%  Nikkei 19,284 -0.5%  EUR 1.0562 -0.4% 
Nasdaq 5,845 0.2%  FTSE100 7,244 -0.4%  Yen 112.1440 0.0%  Oil 56.0 -0.8% 
S&P500 2,367 0.2%  DAX 11,804 -1.2%  GBP 1.2460 0.0%  Gold 1,257 0.6% 

02/17/2017 08:50:08 AM
02/17/2017 08:50:08 AM UTC-0500

Perrigo: FDA Oks Hydrocodone Bitartrate &Homatropine Methylbromide Oral Solution


(RTTNews) - Perrigo Company plc (PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL.

Hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg per 5 mL is indicated for the symptomatic relief of cough in adults and children 6 years of age and older. Annual sales for the 12 months ending January 2017 were about $16 million.

Add or Edit Instrument

Stock Market

News Ticker

News

  • News on Stocks
  • All News
pagehit